Impact of renin-angiotensin-aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort study.
Sato K, White N, Fanning JP, Obonyo N, Yamashita MH, Appadurai V, Ciullo A, May M, Worku ET, Helms L, Ohshimo S, Juzar DA, Suen JY, Bassi GL, Fraser JF, Arora RC; COVID-19 Critical Care Consortium Investigators.
Sato K, et al. Among authors: may m.
BMC Cardiovasc Disord. 2022 Mar 23;22(1):123. doi: 10.1186/s12872-022-02565-1.
BMC Cardiovasc Disord. 2022.
PMID: 35321649
Free PMC article.